Human Allogeneic Liver-Derived Progenitor Cells Significantly Improve NAFLD Activity Score and Fibrosis in Late-Stage NASH Animal Model

Accumulated experimental and clinical evidence supports the development of human allogeneic liver-derived progenitor cells (HALPCs) to treat fibro-inflammatory liver diseases. The aim of the present study was to evaluate their therapeutic effect in a non-alcoholic steatohepatitis (NASH)-STAM mouse m...

Descripción completa

Detalles Bibliográficos
Autores principales: Najimi, Mustapha, Michel, Sébastien, Binda, Maria M., Gellynck, Kris, Belmonte, Nathalie, Mazza, Giuseppe, Gordillo, Noelia, Vainilovich, Yelena, Sokal, Etienne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9497074/
https://www.ncbi.nlm.nih.gov/pubmed/36139429
http://dx.doi.org/10.3390/cells11182854

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9497074/
https://www.ncbi.nlm.nih.gov/pubmed/36139429
http://dx.doi.org/10.3390/cells11182854

Ejemplares similares